PCSK9 and urolithiasis: We used urinary stones as an exposure factor, circulating lipids and lipid-lowering drugs as outcome factors(We did not extract SNPs associated with exposure factors in the GWAS for HMGCR inhibitors and PCSK9 inhibitors).